SCHEMBL27419339

SCHEMBL27419339

C=C[C@@H](c1ccccc1)[C@H](N[S@@+]([O-])C(C)(C)C)C(=O)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 2/20 0.37
MDM4 O15151 1/20 0.37
MAPT P10636 1/20 0.37
MDM2 Q00987 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
PIN1 Q13526 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.34
OPRD1 P41143 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27419336 1.00 MMP8 (0.41) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL29562704 0.88 MAPT (0.35) MMP8SMN1; SMN2LMNAMAPTKDM4E
SCHEMBL30942546 0.87 SLC6A2 (0.38) MEN1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL9687500 0.75 MMP8 (0.49) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL9796658 0.74 MMP8 (0.48) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL7490890 0.72 MMP8 (0.47) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL17857574 0.72 MMP8 (0.42) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL437029 0.72 RIPK1 (0.40) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL9686671 0.71 MMP8 (0.46) MMP8SMN1; SMN2LMNAMDM4MAPT
SCHEMBL27419364 0.71 MMP8 (0.46) MMP8SMN1; SMN2LMNAMDM4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608452-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS Eisai R&D Management Co., Ltd. (JP) 2025-09-03 EP disclosed
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 WO disclosed
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 WO disclosed